Xr Securities LLC Amgen Inc Transaction History

Xr Securities LLC

  • $544 Million
  • Q2 2024

A detailed history of Xr Securities LLC transactions in Amgen Inc stock. As of the latest transaction made, Xr Securities LLC holds 3,500 shares of AMGN stock, worth $1.12 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares
3,500
Previous 14,357 75.62%
Holding current value
$1.12 Million
Previous $4.08 Million 73.22%
% of portfolio
0.2%
Previous 0.13%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$268.87 - $324.56 $3.86 Million - $4.66 Million
14,357 New
14,357 $4.08 Million
Q4 2022

Jan 03, 2023
SELL
$229.03 - $291.01 $4,580 - $5,820
-20 Reduced 0.94%
2,103 $552,000
Q3 2022

Oct 18, 2022
BUY
$224.46 - $253.15 $476,528 - $537,437
2,123 New
2,123 $479,000
Q1 2022

Apr 14, 2022
SELL
$219.27 - $242.57 $375,609 - $415,522
-1,713 Closed
0 $0
Q4 2021

Jan 10, 2022
BUY
$198.88 - $227.6 $340,681 - $389,878
1,713 New
1,713 $385,000
Q3 2021

Oct 14, 2021
SELL
$212.27 - $248.7 $210,571 - $246,710
-992 Closed
0 $0
Q2 2021

Jul 26, 2021
BUY
$233.58 - $259.14 $231,711 - $257,066
992 New
992 $242,000
Q1 2021

Apr 29, 2021
SELL
$221.91 - $258.6 $258,081 - $300,751
-1,163 Closed
0 $0
Q4 2020

Jan 13, 2021
SELL
$216.38 - $257.67 $809,044 - $963,428
-3,739 Reduced 76.27%
1,163 $267,000
Q3 2020

Oct 28, 2020
BUY
$234.65 - $260.95 $1.15 Million - $1.28 Million
4,902 New
4,902 $1.25 Million
Q3 2018

Oct 04, 2018
SELL
$185.29 - $208.89 $220,309 - $248,370
-1,189 Closed
0 $0
Q2 2018

Jul 06, 2018
BUY
$166.05 - $186.51 $197,433 - $221,760
1,189 New
1,189 $219,000

Others Institutions Holding AMGN

# of Institutions
3,052
Shares Held
409M
Call Options Held
7.19M
Put Options Held
6.26M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Xr Securities LLC Portfolio

Follow Xr Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xr Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Xr Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email